17 may 2021
CPhI Discover
Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

Exhibitor at CPhI Discover

About us

Hengrui Medicine is a leading pharmaceutical company based in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. It ranks top 30 worldwide in pharmaceuticals industry by a market capitalization of over 60 billion USD, and is home to more than 21,900 employees worldwide. Hengrui stands out as a front-runner in antineoplastics, contrast agents, and surgical medicines. Producs are approved by US-FDA, EU and PMDA.

Specs about this supplier

Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Affiliated categories: APIs (Active Pharmaceutical Ingredients) |Finished Dosage Forms |Injectables More

Products featured at CPhI Discover

Categories affiliated with Jiangsu Hengrui Medicine Co., Ltd.